Astrana Health (NASDAQ:ASTH) Shares Gap Up Following Analyst Upgrade

Astrana Health, Inc. (NASDAQ:ASTH)’s share price gapped up before the market opened on Wednesday after Robert W. Baird raised their price target on the stock from $67.00 to $86.00. The stock had previously closed at $42.91, but opened at $44.86. Robert W. Baird currently has an outperform rating on the stock. Astrana Health shares last traded at $44.39, with a volume of 50,865 shares.

Several other research analysts have also issued reports on the company. BTIG Research increased their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Truist Financial raised their target price on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. TD Cowen began coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 target price for the company. KeyCorp began coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Stifel Nicolaus raised their target price on Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $65.17.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. GAMMA Investing LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at $35,000. KBC Group NV bought a new stake in shares of Astrana Health during the 3rd quarter valued at $70,000. Quest Partners LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at $133,000. Finally, Central Pacific Bank Trust Division bought a new stake in shares of Astrana Health during the 3rd quarter valued at $160,000. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Price Performance

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.84 and a current ratio of 1.91. The company has a market cap of $2.06 billion, a price-to-earnings ratio of 32.24, a PEG ratio of 2.01 and a beta of 1.24. The business has a fifty day moving average price of $55.30 and a 200 day moving average price of $47.68.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. During the same quarter in the previous year, the firm earned $0.47 EPS. As a group, research analysts anticipate that Astrana Health, Inc. will post 1.16 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.